• Talaris Therapeutics Announces Initiation of Phase 3 Clinical Trial of FCR001 in Living Donor …

    Talaris operates its own cell processing facility in Louisville, KY and maintains corporate offices in Boston, MA and Louisville, KY. Talaris is backed by …

    Read More
  • 0 0